Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,683Revenue $M2,133Net Margin (%)4.1Z-Score3.8
Enterprise Value $M3,418EPS $2.7Operating Margin %6.9F-Score4
P/E(ttm))46.3Cash Flow Per Share $6.5Pre-tax Margin (%)6.1Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %8.4Quick Ratio2.5Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %10.1Current Ratio3.5Lower Leverage y-yN
Price/Cash Flow16.0y-y EBITDA Growth Rate %-31.3ROA % (ttm)2.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M29.0ROI % (ttm)3.8Gross Margin Increase y-yN

Gurus Latest Trades with BIO

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIOJoel Greenblatt 2014-12-31 Add0.24%$106.48 - $121.96
($115.15)
$ 127.1810%Add 5621.13%240,974
BIOMario Gabelli 2014-12-31 Reduce-0.01%$106.48 - $121.96
($115.06)
$ 127.1810%Reduce -21.69%70,400
BIOJohn Rogers 2014-09-30 Add0.13%$114.72 - $121.81
($118.62)
$ 127.187%Add 8.52%1,067,226
BIOJoel Greenblatt 2014-09-30 Buy $114.72 - $121.81
($118.62)
$ 127.187%New holding, 4212 sh.4,212
BIONWQ Managers 2014-06-30 Add0.11%$118.68 - $129.7
($122.14)
$ 127.184%Add 20.72%523,806
BIOJohn Burbank 2014-06-30 Sold Out -0.02%$118.68 - $129.7
($122.14)
$ 127.184%Sold Out0
BIONWQ Managers 2014-03-31 Add0.12%$121.07 - $133.73
($128.05)
$ 127.18-1%Add 30.77%433,899
BIOJohn Burbank 2014-03-31 Buy 0.02%$121.07 - $133.73
($128.05)
$ 127.18-1%New holding, 4652 sh.4,652
BIOJohn Rogers 2014-03-31 Reduce-0.12%$121.07 - $133.73
($128.05)
$ 127.18-1%Reduce -7.06%1,024,729
BIONWQ Managers 2013-12-31 Add0.34%$115.53 - $124.5
($121.87)
$ 127.184%Add 1376.49%331,811
BIOJohn Rogers 2013-09-30 Add0.15%$112.74 - $125.8
($118.02)
$ 127.188%Add 8.32%1,096,613
BIONWQ Managers 2013-09-30 Buy 0.03%$112.74 - $125.8
($118.02)
$ 127.188%New holding, 22473 sh.22,473
BIOPrivate Capital 2013-03-31 Reduce-0.05%$105.05 - $126
($117.3)
$ 127.188%Reduce -22.47%16,887
BIOJoel Greenblatt 2013-03-31 Sold Out -0.04%$105.05 - $126
($117.3)
$ 127.188%Sold Out0
BIOJoel Greenblatt 2012-12-31 Reduce-0.09%$100.02 - $109.55
($103.99)
$ 127.1822%Reduce -65.94%6,350
BIOGeorge Soros 2012-09-30 Sold Out -0.02%$92.4 - $109.42
($101.33)
$ 127.1826%Sold Out0
BIOMario Gabelli 2012-06-30 Add0.07%$95.57 - $116
($103.12)
$ 127.1823%Add 2335.14%90,100
BIOGeorge Soros 2012-06-30 Buy 0.02%$95.57 - $116
($103.12)
$ 127.1823%New holding, 15000 sh.15,000
BIOJoel Greenblatt 2012-03-31 Add0.07%$96.64 - $105.67
($94.65)
$ 127.1834%Add 56.04%22,134
BIOJoel Greenblatt 2011-12-31 Buy 0.16%$88.92 - $102.55
($95.3)
$ 127.1834%New holding, 14185 sh.14,185
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIO Joel Greenblatt 2014-12-31240,9740.830.24+5621.13%
BIO NWQ Managers 2014-12-31558,3781.930.81+6.13%
BIO Private Capital 2014-12-3115,1870.050.2
BIO John Rogers 2014-12-311,060,5673.661.5-0.62%
BIO Ken Fisher 2014-12-31290,17610.07-1.02%
BIO Mario Gabelli 2014-12-3170,4000.240.04-21.69%
Premium Most recent portfolio changes are included for Premium Members only!


BIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Magni GiovanniEVP, Chief Strategy Officer 2014-12-12Sell5,000$117.380.47view
SODERBERG SHAWN MARIEEVP, General Counsel, Sec 2014-12-03Sell83$120-1.72view
HERTIA JOHNExecutive Vice President 2014-11-25Sell6,000$119.39-1.22view
TSINGOS CHRISTINE AEVP and CFO 2014-11-20Sell1,326$115.851.8view
GOETZ JOHNEVP, COO 2014-11-19Sell4,891$114.413.08view
HUTTON RONALD WVice President and Treasurer 2014-11-13Sell3,066$111.625.65view
SCHWARTZ STEVEN D10% Owner 2014-11-13Sell530$111.935.36view
TSINGOS CHRISTINE AEVP and CFO 2014-11-12Sell7,000$112.225.09view
STARK JAMES RVP, Corporate Controller 2014-11-11Sell4,257$112.64.73view

Press Releases about BIO :

    Quarterly/Annual Reports about BIO:

    News about BIO:

    Articles On GuruFocus.com
    Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters With U.S. Government Nov 03 2014 
    Bio-Rad to Report Third-Quarter 2014 Financial Results Tuesday, November 4, 2014 Oct 15 2014 
    Bio-Rad Appoints John Goetz as Chief Operating Officer and Announces Other Executive Appointments Oct 15 2014 
    Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
    Guru Held Stocks Near Historical Low P/B Jul 22 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 23 2014 

    More From Our Partners
    Zacks Rank #5 Additions for Thursday - Tale of the Tape Feb 19 2015 - ZACKS

    More From Other Websites
    Current report 2015/4 dated 22.02.2015 Feb 22 2015
    Zacks Rank #5 Additions for Thursday - Tale of the Tape Feb 19 2015
    Current report 2015/3) dated 16.02.2015 Feb 17 2015
    Zacks Rank #5 Additions for Friday - Tale of the Tape Feb 06 2015
    Bio-Rad to Report Fourth-Quarter and Full-Year 2014 Financial Results Thursday, February 26, 2015 Feb 03 2015
    Frost & Sullivan Recognizes Bio-Rad's Digital PCR Platform, the QX200™ AutoDG™ Droplet... Jan 28 2015
    Current report 2015/1 dated 26.01.2015 Jan 26 2015
    Zacks Rank #5 Additions for Tuesday - Tale of the Tape Jan 13 2015
    Corruption Currents: Former Sony Staffers Suspect Attack Was Inside Job Jan 07 2015
    Bio-Rad Receives Premarket Application Approval for Its Geenius HIV 1/2 Supplemental Assay Nov 18 2014
    BIO RAD LABORATORIES INC Financials Nov 14 2014
    SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible... Nov 12 2014
    Lifshitz & Miller Law Firm Announces Investigation of Barrett Business Services, Inc., Bio-Rad... Nov 11 2014
    SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces an Investigation into Possible Breaches of... Nov 07 2014
    BIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly Report Nov 07 2014
    Ryan & Maniskas, LLP Announces Investigation of Bio-Rad Laboratories, Inc. Nov 05 2014
    BIO-RAD INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC... Nov 05 2014
    Bio-Rad Reports Third-Quarter 2014 Financial Results Nov 04 2014
    Bio-Rad posts 3Q profit Nov 04 2014
    Bio-Rad posts 3Q profit Nov 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK